MetaCap

Entrada Therapeutics Inc. Company Profile

NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.35-0.29 (-6.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Entrada Therapeutics at a glance

Entrada Therapeutics Inc. (NASDAQ: TRDA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boston, MA. Entrada Therapeutics is led by Mr. Dipal Doshi and employs about 152 people. The company's shares have traded publicly since 2021.

At a market capitalization of $170.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001689375, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Entrada Therapeutics do?

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Entrada Therapeutics Inc.
Ticker
NASDAQ: TRDA
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Dipal Doshi
Employees
152
Headquarters
One Design Center Place, Boston, MA, United States
Phone
857 520 9158
IPO year
2021
Market cap
$170.30M
SEC CIK
0001689375
Latest annual report
10-K · Feb 26, 2026

Companies similar to Entrada Therapeutics

TRDA peer companies
CompanyPrice% ChgMarket capCompare
SIGASIGA Technologies Inc.2.40-9.43%$172.45Mvs TRDA
KRROKorro Bio Inc.12.18-0.08%$167.18Mvs TRDA
ABEOAbeona Therapeutics Inc.2.42-1.22%$165.31Mvs TRDA
VOGXVogenx Inc11.87-7.30%$176.33Mvs TRDA
NATRNature's Sunshine Products Inc.10.18+0.10%$176.41Mvs TRDA
EMISEmmis Acquisition Corp. Class A10.36+0.15%$163.36Mvs TRDA
ADCTADC Therapeutics SA1.28-1.54%$180.05Mvs TRDA
SLGLSol-Gel Technologies Ltd.55.17+2.02%$180.63Mvs TRDA

Related